Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference

On March 6, 2018 Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, reported that David Domzalski, Chief Executive Officer, will present a corporate overview and business update at the Cowen and Company 38th Annual Health Care Conference, taking place March 12-14 at the Boston Marriott Copley Place hotel in Boston, Massachusetts (Press release, Foamix, MAR 6, 2018, View Source [SID1234524446]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 38th Annual Health Care Conference
Date: Tuesday, March 13
Time: 9:20am Eastern Time
Location: Boston Marriott Copley Place
Webcast: http://wsw.com/webcast/cowen46/fomx/